Cristina Rondinone
Keine laufenden Positionen mehr
Vermögen: - $ am 31.12.2023
Karriereverlauf von Cristina Rondinone
Ehemalige bekannte Positionen von Cristina Rondinone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AXCA HEALPAR | Direktor/Vorstandsmitglied | 27.06.2018 | 01.11.2023 |
| Independent Dir/Board Member | 27.06.2018 | 01.11.2023 | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Präsident | 01.09.2019 | 01.06.2020 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.03.2011 | 01.09.2019 |
| University of Gothenburg | Corporate Officer/Principal | - | - |
Ausbildung von Cristina Rondinone
| Universidad de Buenos Aires | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Argentinien | 2 |
| Schweden | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AXCA HEALPAR | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Cristina Rondinone
- Erfahrung
